'Invisible' protein keeps cancer at bay
- Details
- Category: Research
EMBL Hamburg's Wilmanns Group, in collaboration with research groups from the Center for Experimental Medicine Institute of Tumor Biology and the Martini Clinic at the University Medical Center Hamburg-Eppendorf (UKE), as well as the Leibniz Institute on Aging - Fritz Lipmann Institute, has revealed a new mechanism
Existing high blood pressure drugs may prevent epilepsy
- Details
- Category: Research
The study, published June 17 in JAMA Neurology, suggests that the drugs, called angiotensin receptor blockers, could prevent epilepsy in people at highest risk of the disease, including older adults who have had strokes.
A new tuberculosis vaccine candidate
- Details
- Category: Research
The current anti-tuberculosis vaccine, BCG, is administered worldwide. However, considering that more than 10 million new tuberculosis cases are reported each year, its effectiveness is deemed insufficient.
Nano-immunotherapy developed to improve lung cancer treatment
- Details
- Category: Research
Obesity-cancer connection discovery suggests strategies for improving immunotherapy
- Details
- Category: Research
Obesity increases the frequency of macrophages in tumors and induces their expression of the immune checkpoint protein PD-1 - a target of cancer immunotherapies. The findings, published June 12 in the journal Nature, provide a mechanistic explanation for how obesity can contribute to both increased cancer risk and enhanced responses to immunotherapy.
An easier, less expensive way to power precision medicine
- Details
- Category: Research
This makes monitoring proteins and their molecular changes - the study of proteomics - beneficial for drug discovery, disease diagnosis and health management.
Preparing for a world where Alzheimer's disease is treatable
- Details
- Category: Research
Alzheimer's disease is the most common cause of dementia. Of the 944,000 people living with dementia in the UK, 60-80% have Alzheimer's.
More Pharma News ...
- Protein study could help researchers develop new antibiotics
- Treating rare skin diseases by transplanting healthy skin
- UBC-developed oral insulin drops offer relief for diabetes patients
- Protein discovery could help prevent cancer treatment-related heart damage
- The future of drug testing: Vascularized organ-on-a-chip technologies
- Two-Pronged Attack Strategy Boosts Immunotherapy in Preclinical Studies
- Intermittent fasting shows promise in improving gut health, weight management